Somatostatin receptor subtypes 2 and 5 are associated with better survival in operable hepatitis B-related hepatocellular carcinoma following octreotide long-acting release treatment

Liver resections for hepatocellular carcinoma (HCC) in cirrhotic livers are associated with early recurrence and poor survival. Somatostatin analogues (SSAs) have been reported to inhibit cell proliferation by interacting with specific somatostatin receptors (SSTRs) 2 and 5. The present study invest...

Descripció completa

Dades bibliogràfiques
Autors principals: LIU, YAO, JIANG, LI, MU, YI
Format: Online Article Text
Idioma:English
Publicat: D.A. Spandidos 2013
Matèries:
Articles
Accés en línia:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3789087/
https://www.ncbi.nlm.nih.gov/pubmed/24137418
http://dx.doi.org/10.3892/ol.2013.1435

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3789087/
https://www.ncbi.nlm.nih.gov/pubmed/24137418
http://dx.doi.org/10.3892/ol.2013.1435

Ítems similars